SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Who pays when an AI agent tries again?

Brandlight helps enterprise marketers manage how AI recommends their brand

BlueGreen Water Technologies turns algae blooms into large-scale carbon removal

Taboola to acquire Dianomi for up to £27 million as it pushes deeper into finance advertising

Buzz

Most popular

Daily

Weekly

1

Serbia opens Israeli drone factory as defense ties with Elbit deepen

2

The man who helped build Palo Alto’s Cortex is leaving the company

3

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

4

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

5

Sayeret Matkal veterans raise $22 million to teach the world English with AI

Omnix Medical

4 stories about Omnix Medical

Omnix Medical team

EU backs Israeli antibiotic developer with €8 million grant to combat deadly superbugs

Omnix Medical will lead a European consortium aimed at accelerating late-stage development of its experimental treatment for drug-resistant hospital infections.

מימין מושיק כהן קוטנר נדב בחנוף חברת אומניקס מדיקל

Omnix Medical raises $25 million Series C to tackle drug-resistant infections

Israeli biotech secures funding to complete Phase II trials for its novel antimicrobial peptide therapy.

רום לקריץ מושיק כהן קוטנר ו ניב בחנוף אומניקס מדיקל Omnix Medical

Israeli biopharma startup Omnix Medical awarded €10.8 million from EU to fight drug-resistant bacteria

26.01.21|Meir Orbach

The novel agents developed by Omnix are designed as an alternative to classical antibiotics

רום לקריץ מושיק כהן קוטנר ו ניב בחנוף אומניקס מדיקל Omnix Medical

Omnix Medical completes $8.5 million round to develop next-generation antibiotics for treatment of life-threatening infections

03.11.20|Meir Orbach

The Israeli startup has successfully completed testing in animals and the new funding will allow it to begin clinical trials with humans